747 completed, 274 unknown, 208 recruiting, 136 terminated. 499 Phase 2, 285 Phase 3, 193 Phase 1, 165 Not applicable, 108 Phase 4.
Follow Cytopenia: new trials by email Literature Review of Cytopenia trials Research Report on Cytopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy NM8074 - aHUS - Atypical Hemolytic Uremic Syndrome | Phase 2 | Not yet recruiting | NovelMed Therapeutics | 12 | 2027-11-01 | 2026-04-13 |
| Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy ceftazidime, ciprofloxacin, Standard-of-Care Antibiotic Strategy - Large B-Cell Lymphoma (LBCL), Multiple Myeloma (MM) | Phase 2 | Not yet recruiting | Zealand University Hospital | 150 | 2027-03-01 | 2026-09-25 |
| G-CSF In Neonatal Sepsis With Neutropenia Granulocyte-colony stimulating factor (G-CSF), Standard Sepsis Management - Neonatal Sepsis, Neutropenia | Not applicable | Not yet recruiting | University of Health Sciences Lahore | 52 | 2027-02-15 | 2026-10-22 |
| A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids. Ianalumab, Eltrombopag - Primary Immune Thrombocytopenia (ITP) | Phase 2 | Not yet recruiting | Novartis Pharmaceuticals | 36 | 2027-02-08 | 2026-06-25 |
| Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias RXIM002 - Immune Thrombocytopenia (ITP) | Phase 1 | Not yet recruiting | RiboX Therapeutics Ltd. | 27 | 2027-02-01 | 2026-10-28 |
| Diagnostic Accuracy, Clinical Utility and Implementation of Point-of-Care Absolute Neutrophil Count in Suspected Neutropenic Fever (DUCATIS) - Diagnostic Accuracy (S1) Hemocue® WBC DIFF system - Suspected Neutropenic Fever, Confirmed Neutropenic Fever | Not applicable | Not yet recruiting | The University of Hong Kong | 317 | 2027-01-01 | 2026-10-28 |
| An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1 CAR-T cells targeting CD19 - Pemphigus Vulgaris (PV), ANCA Associated Vasculitis (AAV) | Phase 1 / Phase 2 | Not yet recruiting | University Hospital Tuebingen | 36 | 2027-01-01 | 2026-11-12 |
| A Clinical Study Evaluating the Safety and Preliminary Effectiveness of Induced Pluripotent Stem Cell-derived Platelets in Patients With Thrombocytopenia Caused by Allogeneic Hematopoietic Stem Cell Transplantation iPSC-derived platelets - Thrombocytopenia | Early Phase 1 | Not yet recruiting | Ruijin Hospital | 9 | 2026-12-30 | 2026-10-29 |
| A Study to Compare the Pharmacokinetics, Pharmacodynamics, Immunogenicity, Safety and Tolerability of Filgrastim Biosimilar and Neupogen Reference Product in Healthy Volunteers Biofilgragen, Neupogen (filgrastim) - Neutropenia (Low White Blood Cell Count) | Phase 1 | Not yet recruiting | BioGeneric Pharma | 50 | 2026-12-15 | 2026-10-20 |
| Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia Remote temperature monitoring device, Home temperature monitoring by a nurse - Oncopediatrics, Febrile Neutropenia | Not applicable | Not yet recruiting | Centre Hospitalier Universitaire de la Réunion | 30 | 2026-12-01 | 2026-10-23 |
| Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma Acupuncture - Febrile Neutropenia, Sarcoma | Not applicable | Not yet recruiting | Shaare Zedek Medical Center | 60 | 2026-12-01 | 2026-04-29 |
| A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA Velinotamig specified dose on specified days. - Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (WAIHA) | Phase 1 / Phase 2 | Not yet recruiting | Cullinan Therapeutics Inc. | 72 | 2026-12-01 | 2026-07-31 |
| Study of LusPACercept in Participants With Myelofibrosis Associated Anemia and Thrombocytopenia Luspatercept, Pacritinib - Myelofibrosis | Phase 2 | Not yet recruiting | Case Comprehensive Cancer Center | 50 | 2026-12-01 | 2026-11-13 |
| Sequential Hetrombopag and Recombinant Human Thrombopoietin for Cancer Therapy-Induced Thrombocytopenia Hetrombopag and recombinant human thrombopoietin, Recombinant Human Thrombopoietin - Thrombocytopenia | Phase 2 | Not yet recruiting | The First Affiliated Hospital of Zhengzhou University | 96 | 2026-12-01 | 2026-11-12 |
| Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia Zanubrutinib 80mg/d, High dose dexamethasone, Zanubrutinib 160mg/d - Immune Thrombocytopenia | Phase 2 | Not yet recruiting | Peking University People's Hospital | 90 | 2026-12-01 | 2026-11-12 |
| Hematological Safety of Dipyrone Versus Paracetamol After Dental Extractions Dipyrone administration, Paracetamol (drug), blood sampling - Hematologic Test, Agranulocytosis | Phase 4 | Recruiting | Matheus Furtado de Carvalho | 50 | 2026-11-13 | 2026-11-06 |
| Time-limited Treatment With Avatrombopag Pre- and Post-CAR T-cell Therapy to Prevent Post-CAR T-cell Cytopenias Avatrombopag - Thrombocytopenia | Phase 2 | Not yet recruiting | University of Virginia | 26 | 2026-11-01 | 2026-10-26 |
| Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation Romiplostim N01 - Thrombocytopenia, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2 | Not yet recruiting | The First Affiliated Hospital of Henan University of Science and Technology | 87 | 2026-11-01 | 2026-09-21 |
| Study of Thyroid Dysfunction in Immune Thrombocytopenic Purpura Patients Laboratory tests TSH, FT3, FT4 ,anti thyroglobulin antibodies, Anti -TPO antibodies - Thyroid Dysfunction, Immune Thrombocytopenic Purpura | Not yet recruiting | Sohag University | 50 | 2026-10-25 | 2026-10-28 | |
| TGD001 Treatment in Thrombotic Microangiopathies TGD001 - Thrombotic Microangiopathies, ITP Immune-Mediated Thrombocytopenia | Phase 1 / Phase 2 | Recruiting | TargED Biopharmaceuticals B.V. | 70 | 2026-10-25 | 2026-11-12 |
Showing 20 of 1567. Sign in to see all of them.
Purpura, Thrombocytopenic, Idiopathic (483) · Thrombocytopenia (415) · Neutropenia (293) · Febrile Neutropenia (145) · Myelodysplastic Syndromes (66) · Purpura, Thrombotic Thrombocytopenic (65) · Neoplasms (64) · Breast Neoplasms (62) · Anemia (59) · Hematologic Diseases (58) · Leukemia, Myeloid, Acute (54) · Thrombotic Microangiopathies (49) · Hematologic Neoplasms (48) · Fever (47)
Hemic and Lymphatic Diseases (1567) · Hematologic Diseases (1509) · Blood Platelet Disorders (1010) · Pathological Conditions, Signs and Symptoms (781) · Pathologic Processes (726) · Immune System Diseases (723) · Signs and Symptoms (621) · Thrombocytopenia (600) · Blood Coagulation Disorders (599) · Thrombotic Microangiopathies (590) · Hemorrhagic Disorders (559) · Skin Manifestations (550) · Hemorrhage (545) · Purpura (531)
eltrombopag (106) · romiplostim (54) · Dexamethasone (49) · Rituximab (48) · Filgrastim (43) · avatrombopag (42) · pegfilgrastim (40) · Cyclophosphamide (27) · Thrombopoietin (22) · Blood Specimen Collection (21) · Immunoglobulins, Intravenous (21) · Prednisone (19) · Cyclosporine (16) · eculizumab (15) · Danazol (14)
Peking University People's Hospital (55) · Shandong University (44) · Amgen (43) · Institute of Hematology & Blood Diseases Hospital, China (40) · National Heart, Lung, and Blood Institute (NHLBI) (32) · GlaxoSmithKline (29) · Novartis Pharmaceuticals (27) · Assistance Publique - Hôpitaux de Paris (26) · Alexion Pharmaceuticals, Inc. (21) · Assiut University (21) · Pfizer (17) · M.D. Anderson Cancer Center (16) · Eisai Inc. (13) · National Cancer Institute (NCI) (13) · National Institute of Allergy and Infectious Diseases (NIAID) (13)
United States (515) · China (326) · France (197) · Italy (135) · Germany (123) · United Kingdom (117) · Spain (110) · Canada (89) · Poland (71) · South Korea (70) · Australia (69) · Netherlands (68) · Belgium (58) · Japan (54) · Russia (53)
Lei Zhang, MD (18) · Xiao-Hui Zhang, MD (14) · Xiaohui Zhang, MD (10) · Ming Hou, Dr (6) · James Bussel, MD (5) · Ming Hou (5) · Ming Hou, Dr. (5) · Cindy Leissinger, MD (4)
PMID 33783815, PMID 19005182, PMID 19846889, PMID 29958797, PMID 39903535, PMID 40277027, PMID 19671919, PMID 23738544, PMID 24802773, PMID 29419434, PMID 29674506, PMID 32031570, PMID 32171076, PMID 34219224, PMID 34724566, PMID 24254965, PMID 26231455, PMID 26688484, PMID 29515037, PMID 33995988, PMID 35075289, PMID 12944568, PMID 17077333, PMID 18242413, PMID 19549917, PMID 20546023, PMID 21533818, PMID 22067384, PMID 22117897, PMID 22409309, PMID 22494019, PMID 23053510, PMID 23293082, PMID 23317527, PMID 23470153, PMID 23492914, PMID 24802775, PMID 25566808, PMID 26480931, PMID 27658437, PMID 27734464, PMID 28637287, PMID 29042367, PMID 29536526, PMID 29778606, PMID 30900158, PMID 30992268, PMID 32047671, PMID 33031789, PMID 33275766
2023 (15), 2014 (10), 2018 (10), 2019 (7), 2016 (6), U01HL072268 (6), 2009 (5), 2017 (4), 2025 (4), P30CA016672 (3), 2015 (2), P01HL046925 (2), P30CA015083 (2), P30CA015704 (2), U10CA095861 (2)